[go: up one dir, main page]

NO309679B1 - Arylalkyldiazinoner, farmasöytiske preparater og anvendelse av forbindelsene til fremstilling av legemidler - Google Patents

Arylalkyldiazinoner, farmasöytiske preparater og anvendelse av forbindelsene til fremstilling av legemidler Download PDF

Info

Publication number
NO309679B1
NO309679B1 NO963852A NO963852A NO309679B1 NO 309679 B1 NO309679 B1 NO 309679B1 NO 963852 A NO963852 A NO 963852A NO 963852 A NO963852 A NO 963852A NO 309679 B1 NO309679 B1 NO 309679B1
Authority
NO
Norway
Prior art keywords
formula
compounds
acid
acceptable salts
physiologically acceptable
Prior art date
Application number
NO963852A
Other languages
English (en)
Norwegian (no)
Other versions
NO963852D0 (no
NO963852L (no
Inventor
Rochus Jonas
Michael Wolf
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO963852D0 publication Critical patent/NO963852D0/no
Publication of NO963852L publication Critical patent/NO963852L/no
Publication of NO309679B1 publication Critical patent/NO309679B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polymerization Catalysts (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Saccharide Compounds (AREA)
NO963852A 1995-09-14 1996-09-13 Arylalkyldiazinoner, farmasöytiske preparater og anvendelse av forbindelsene til fremstilling av legemidler NO309679B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19533975A DE19533975A1 (de) 1995-09-14 1995-09-14 Arylalkyl-diazinone

Publications (3)

Publication Number Publication Date
NO963852D0 NO963852D0 (no) 1996-09-13
NO963852L NO963852L (no) 1997-03-17
NO309679B1 true NO309679B1 (no) 2001-03-12

Family

ID=7772083

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963852A NO309679B1 (no) 1995-09-14 1996-09-13 Arylalkyldiazinoner, farmasöytiske preparater og anvendelse av forbindelsene til fremstilling av legemidler

Country Status (24)

Country Link
US (1) US5859008A (uk)
EP (1) EP0763534B1 (uk)
JP (1) JP4149532B2 (uk)
KR (1) KR970015578A (uk)
CN (1) CN1110495C (uk)
AT (1) ATE233258T1 (uk)
AU (1) AU716113B2 (uk)
BR (1) BR9603736A (uk)
CA (1) CA2185397C (uk)
CZ (1) CZ286567B6 (uk)
DE (2) DE19533975A1 (uk)
DK (1) DK0763534T3 (uk)
ES (1) ES2192213T3 (uk)
HU (1) HUP9602511A3 (uk)
MX (1) MX9604020A (uk)
NO (1) NO309679B1 (uk)
PL (1) PL185961B1 (uk)
PT (1) PT763534E (uk)
RU (1) RU2167159C2 (uk)
SI (1) SI0763534T1 (uk)
SK (1) SK281474B6 (uk)
TW (1) TW363063B (uk)
UA (1) UA48946C2 (uk)
ZA (1) ZA967766B (uk)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502699A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone
ATE258930T1 (de) * 1997-12-15 2004-02-15 Altana Pharma Ag Dihydrobenzifurane
ATE270278T1 (de) * 1998-03-14 2004-07-15 Altana Pharma Ag Phthalazinone pde iii/iv hemmer
SK287231B6 (sk) 1999-08-21 2010-04-07 Nycomed Gmbh Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
AU781503B2 (en) 1999-10-25 2005-05-26 Altana Pharma Ag Phthalazinone derivatives as PDE 4 inhibitors
SK7232002A3 (en) 1999-10-25 2002-09-10 Byk Gulden Lomberg Chem Fab Tetrahydrothiopyranphthalazinone derivatives as pde4 inhibitors
JP2003535850A (ja) 2000-06-05 2003-12-02 アルタナ ファルマ アクチエンゲゼルシャフト β−２−アドレナリン受容体として効果的な化合物並びにＰＤＥ４−インヒビター
DE10064997A1 (de) * 2000-12-23 2002-06-27 Merck Patent Gmbh Benzoylpyridazine
EP1368035A1 (en) * 2001-02-12 2003-12-10 MERCK PATENT GmbH Use of type 4 phosphodiesterase inhibitors in myocardial diseases
KR20030074817A (ko) 2001-02-15 2003-09-19 알타나 파마 아게 Ｐｄｅ4 억제제로서의 프탈라지논-피페리디노-유도체
BR0209149A (pt) 2001-04-25 2004-07-13 Altana Pharma Ag Ftalazinonas
EA200301101A1 (ru) 2001-04-25 2004-04-29 Алтана Фарма Аг Производные пиперазина и их применение в качестве ингибиторов pde4
RU2004104945A (ru) * 2001-07-18 2005-07-10 Мерк Патент ГмбХ (DE) Производные 4-(бензилиденамино)-3-(метилсульфанил)-4h-1,2,4-триазин-5-она, обладающие ингибирующим действием по отношению к фосфодиэстеразе iv и антагонистичным действием по отношению к tnf, для лечения сердечных заболеваний и аллергии
DE10150517A1 (de) * 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
RU2203892C1 (ru) * 2001-10-12 2003-05-10 Белушкина Наталья Николаевна 2,2,6,6-тетракис(трифторметил)-4-этиламино-5,6-дигидро-1,3,5-оксадиазин ("синтазин"), способ его получения и фармацевтическая композиция на их основе
CA2462525A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Type 4 phosphodiesterase inhibitors and uses thereof
ES2195785B1 (es) * 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
DE10227269A1 (de) * 2002-06-19 2004-01-08 Merck Patent Gmbh Thiazolderivate
CN1671695A (zh) 2002-08-10 2005-09-21 奥坦纳医药公司 用作pde4抑制剂的吡咯烷二酮取代的哌啶－2,3－二氮杂萘酮化合物
US20060167001A1 (en) * 2002-08-10 2006-07-27 Sterk Jan G Pyridazinone-derivatives as pde4 inhibitors
ES2211344B1 (es) * 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
AU2004226353A1 (en) 2003-04-01 2004-10-14 Laboratoires Serono Sa Inhibitors of phosphodiesterases in infertility
AU2005210042B2 (en) 2004-02-04 2011-04-21 Takeda Gmbh 2-(piperidin-4-yl) -4, 5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
WO2005075437A1 (en) * 2004-02-04 2005-08-18 Altana Pharma Ag Pyridazinone derivatives and their use as pde4 inhibitors
ES2251866B1 (es) * 2004-06-18 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2251867B1 (es) * 2004-06-21 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド 神経発生のｇａｂａ受容体媒介調節
DE102005055354A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine
DE102005055355A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
ES2320954B1 (es) * 2007-03-02 2010-03-16 Laboratorio Almirall S.A. Nuevo procedimiento de preparacion de 3-metil-4-fenilisoxazolo (3,4-d)iridazin-7(6h)-ona.
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2017161119A1 (en) 2016-03-16 2017-09-21 H. Lee Moffitt Cancer Center & Research Institute, Inc. Small molecules against cereblon to enhance effector t cell function
PE20210184A1 (es) 2018-07-11 2021-02-02 H Lee Moffitt Cancer Ct & Res Compuestos inmunomoduladores dimericos contra mecanismos basados en cereblon

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788476A (fr) * 1971-09-08 1973-03-06 Sandoz Sa Nouveaux derives de la pyridazinone, leur preparation et leur application comme medicaments
DE3505609A1 (de) * 1985-02-19 1986-08-21 Merck Patent Gmbh, 6100 Darmstadt Benzimidazolyl-pyridazinone
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
DE3734083A1 (de) * 1987-10-08 1989-04-20 Heumann Pharma Gmbh & Co Benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
DE4134893A1 (de) * 1991-10-23 1993-04-29 Merck Patent Gmbh Thiadiazinone
US5326766A (en) * 1992-08-19 1994-07-05 Dreikorn Barry A 4-(2-(4-(2-pyridinyloxy)phenyl)ethoxy)quinazoline and analogues thereof
DE4310699A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone
IL110040A (en) * 1993-06-29 2000-07-16 Nissan Chemical Ind Ltd Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them
DE4330915C1 (de) * 1993-09-11 1994-09-08 Steinel Bernhard Werkzeugmasch Palettenwechsler für Werkzeugmaschinen
DE19500558A1 (de) * 1995-01-11 1996-07-18 Merck Patent Gmbh 3-Alkoxycarbonyl-thiadiazinone
DE19502699A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone
DE19514568A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Arylalkyl-pyridazinone

Also Published As

Publication number Publication date
SK110096A3 (en) 1997-08-06
HU9602511D0 (en) 1996-11-28
CZ286567B6 (cs) 2000-05-17
CA2185397A1 (en) 1997-03-15
JP4149532B2 (ja) 2008-09-10
CA2185397C (en) 2010-01-05
KR100435301B1 (uk) 2004-09-07
PL185961B1 (pl) 2003-09-30
RU2167159C2 (ru) 2001-05-20
EP0763534A1 (de) 1997-03-19
HUP9602511A3 (en) 1998-04-28
ATE233258T1 (de) 2003-03-15
NO963852D0 (no) 1996-09-13
SK281474B6 (sk) 2001-04-09
SI0763534T1 (en) 2003-10-31
NO963852L (no) 1997-03-17
MX9604020A (es) 1997-03-29
BR9603736A (pt) 1998-05-26
CN1157287A (zh) 1997-08-20
HUP9602511A2 (en) 1997-03-28
EP0763534B1 (de) 2003-02-26
UA48946C2 (uk) 2002-09-16
PT763534E (pt) 2003-07-31
JPH09124611A (ja) 1997-05-13
ZA967766B (en) 1997-03-26
AU6551796A (en) 1997-03-20
TW363063B (en) 1999-07-01
DE59610164D1 (de) 2003-04-03
AU716113B2 (en) 2000-02-17
PL316070A1 (en) 1997-03-17
CN1110495C (zh) 2003-06-04
CZ263096A3 (cs) 1998-03-18
DE19533975A1 (de) 1997-03-20
DK0763534T3 (da) 2003-06-10
KR970015578A (ko) 1997-04-28
US5859008A (en) 1999-01-12
ES2192213T3 (es) 2003-10-01

Similar Documents

Publication Publication Date Title
NO309679B1 (no) Arylalkyldiazinoner, farmasöytiske preparater og anvendelse av forbindelsene til fremstilling av legemidler
NO312295B1 (no) Arylalkanoylpyridaziner, fremgangsmåte for fremstilling derav, farmasöytiske preparater, fremgangsmåte for fremstillingderav, samt anvendelse av forbindelsene til fremstilling avpreparatene
CA2672521C (en) Pyrazole derivatives as protein kinase inhibitors
JP2025522631A (ja) Ｐｒｍｔ５阻害剤及びその使用
EP4117784B1 (en) Gpr52 modulator compounds
WO2006085685A1 (ja) ピラゾール化合物
SK118494A3 (en) Piperidine derivatives, method on their production, pharmaceutical agents on their base and method of their production, and using of these derivatives for production of treatments
WO1997019078A1 (fr) DERIVES DE PYRIDO[2,3-d] PYRIMIDINE ET LEURS COMPOSES A USAGE MEDICAL
JP4740116B2 (ja) 精神疾患および神経障害の処置のための５−ｈｔ受容体アンタゴニスト
NO317888B1 (no) Arylalkanoylpyridaziner, fremgangsmate for fremstilling av forbindelsene, forbindelsene foranvendelse som legemidler, farmasoytiske preparater som inneholder dem, fremgangsmatefor fremstilling av preparatene, samt anvendelse av forbindelsene til fremstilling av legemidler
AU2022202463A1 (en) Tetrahydroisoquinoline compound, preparation method therefor, pharmaceutical composition containing same, and use thereof
AU759328B2 (en) Benzoylpyridazines
AU2004218161B2 (en) Benzofuran derivative
NO313415B1 (no) Oksazolidiner, fremgangsmåte for fremstilling derav, farmasöytiske preparater, fremgangsmåte for fremstilling derav,forbindelsene 5-HT2A-antagonister, samt anvendelse avforbindelsene til fremstilling av legemidler
WO2001032173A1 (en) Kainic acid neurocytotoxicity inhibitors
US6107295A (en) Arylalkanoyl pyridazines
WO2000009488A1 (en) Pyridazinone derivatives
KR101586714B1 (ko) 피라졸 화합물
MXPA01010034A (es) Uso de arilalcanoilpiridazinas.
TWI643847B (zh) Novel benzoazepine derivatives and their medical uses
Branigan Darmstadt, all of Germany
KR20230051939A (ko) 신규한 캡시드 조립 저해제
MXPA99003479A (en) New heterocyclylmethyl-substituted pyrazol derivates
MXPA00012592A (en) Aryl alkanoylpyridazines
MXPA99007866A (en) Oxazolidines as 5-ht2a-antagonists

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees